Last reviewed · How we verify

NCT07095608

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain

Recruiting now NA Last updated 21 November 2025
What this trial tests

NA trial testing Pressure and stretch sensitivity testing in Oral Cancer in 80 participants. Currently enrolling.

Timeline
1 September 2025
Primary endpoint
30 June 2029
30 December 2029

Quick facts

Lead sponsorNew York University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment80
Start date1 September 2025
Primary completion30 June 2029
Estimated completion30 December 2029
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

New York University

Who can join

18 and older, any sex, with Oral Cancer or Squamous Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective study involving human participants. Pressure and stretch sensitivity measures between oral cancer patients and healthy subjects will be compared. Pain stimulation will be conducted on the site of the cancer in 40 oral cancer patients, and on the tongue in 40 healthy volunteers, using pressure and stretch sensitivity tests.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oral Cancer

Currently open trials in the same condition.

Other New York University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07095608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing